Submitted:
30 May 2023
Posted:
01 June 2023
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Virus Genome Data
2.2. Phylogenetic and Cluster Analysis
2.3. Enumeration of Sequence Motifs
2.4. Statistical Analyses
3. Results
3.1. Topological Comparisons
3.2. Sliding Window Analysis
3.3. Principal Component Analysis
3.4. Ancestral State Reconstruction
3.5. Phylogenetic Independent Contrasts
3.6. Codon-based Selection
4. Discussion
Supplementary Materials
Author Contributions
Funding
Data Availability Statement
Acknowledgments
Conflicts of Interest
References
- Bernard, H.-U.; Burk, R.D.; Chen, Z.; Van Doorslaer, K.; zur Hausen, H.; de Villiers, E.-M. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 2010, 401, 70–79, . [CrossRef]
- Kraberger, S.; Austin, C.; Farkas, K.; Desvignes, T.; Postlethwait, J.H.; Fontenele, R.S.; Schmidlin, K.; Bradley, R.W.; Warzybok, P.; Van Doorslaer, K.; et al. Discovery of novel fish papillomaviruses: From the Antarctic to the commercial fish market. Virology 2022, 565, 65–72, . [CrossRef]
- Russo, A.G.; Harding, E.F.; Yan, G.J.H.; Selechnik, D.; Ducatez, S.; DeVore, J.L.; Zhou, J.; Sarma, R.R.; Lee, Y.P.; Richardson, M.F.; et al. Discovery of Novel Viruses Associated With the Invasive Cane Toad (Rhinella marina) in Its Native and Introduced Ranges. Front. Microbiol. 2021, 12, 733631. [CrossRef]
- Truchado, D.A.; Williams, R.A.; Benítez, L. Natural history of avian papillomaviruses. Virus Res. 2018, 252, 58–67, . [CrossRef]
- Van Doorslaer, K.; Li, Z.; Xirasagar, S.; Maes, P.; Kaminsky, D.; Liou, D.; Sun, Q.; Kaur, R.; Huyen, Y.; McBride, A.A. The Papillomavirus Episteme: a major update to the papillomavirus sequence database. Nucleic Acids Res. 2017, 45, D499–D506, . [CrossRef]
- Walker, P.J.; Siddell, S.G.; Lefkowitz, E.J.; Mushegian, A.R.; Adriaenssens, E.M.; Dempsey, D.M.; Dutilh, B.E.; Harrach, B.; Harrison, R.L.; Hendrickson, R.C.; et al. Changes to virus taxonomy and the Statutes ratified by the International Committee on Taxonomy of Viruses (2020). Arch. Virol. 2020, 165, 2737–2748, . [CrossRef]
- Mühr, L.S.A.; Eklund, C.; Dillner, J. Towards quality and order in human papillomavirus research. Virology 2018, 519, 74–76, . [CrossRef]
- Bruni L, A.G., Serrano B, Mena M, Collado JJ, Gómez D, Muñoz J, Bosch FX, de Sanjosé S., ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in the World. 2021.
- zur Hausen, H. Papillomaviruses and cancer: From basic studies to clinical application. Nat. Rev. Cancer 2002, 2, 342–350, . [CrossRef]
- Kidd, L.C.; Chaing, S.; Chipollini, J.; Giuliano, A.R.; Spiess, P.E.; Sharma, P. Relationship between human papillomavirus and penile cancer—implications for prevention and treatment. Transl. Androl. Urol. 2017, 6, 791–802, . [CrossRef]
- Sabatini, M.E.; Chiocca, S. Human papillomavirus as a driver of head and neck cancers. Br. J. Cancer 2020, 122, 306–314, . [CrossRef]
- Münger, K.; Baldwin, A.; Edwards, K.M.; Hayakawa, H.; Nguyen, C.L.; Owens, M.; Grace, M.; Huh, K. Mechanisms of Human Papillomavirus-Induced Oncogenesis. J. Virol. 2004, 78, 11451–60, . [CrossRef]
- Schiffman, M.; Rodriguez, A.C.; Chen, Z.; Wacholder, S.; Herrero, R.; Hildesheim, A.; Desalle, R.; Befano, B.; Yu, K.; Safaeian, M.; et al. A Population-Based Prospective Study of Carcinogenic Human Papillomavirus Variant Lineages, Viral Persistence, and Cervical Neoplasia. Cancer Res 2010, 70, 3159–3169, . [CrossRef]
- Byun, J.M.; Jeong, D.H.; Kim, Y.N.; Jung, E.J.; Lee, K.B.; Sung, M.S.; Kim, K.T. Persistent HPV-16 infection leads to recurrence of high-grade cervical intraepithelial neoplasia. Medcine 2018, 97, e13606, doi:10.1097/md.0000000000013606.
- Wei, F., et al., Age-specific prevalence of anal and cervical HPV infection and high-grade lesions in 11 177 women by HIV status: a collaborative pooled analysis of 26 studies. J Infect Dis, 2022.
- Arbyn, M.; Weiderpass, E.; Bruni, L.; de Sanjosé, S.; Saraiya, M.; Ferlay, J.; Bray, F. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis [published correction appears in Lancet Glob Health. 2022 Jan;10,e41]. Lancet Glob. Health 2020, 8, e191–e203, doi:10.1016/s2214-109x(19)30482-6.
- Schiffman, M.; Herrero, R.; DeSalle, R.; Hildesheim, A.; Wacholder, S.; Rodriguez, A.C.; Bratti, M.C.; Sherman, M.E.; Morales, J.; Guillen, D.; et al. The carcinogenicity of human papillomavirus types reflects viral evolution. Virology 2005, 337, 76–84, . [CrossRef]
- Burk, R.D.; Chen, Z.; Van Doorslaer, K. Human Papillomaviruses: Genetic Basis of Carcinogenicity. Public Heal. Genom. 2009, 12, 281–290, . [CrossRef]
- Bouvard, V.; Baan, R.; Straif, K.; Grosse, Y.; Secretan, B.; El Ghissassi, F.; Benbrahim-Tallaa, L.; Guha, N.; Freeman, C.; Galichet, L.; et al. A review of human carcinogens—Part B: biological agents. Lancet Oncol. 2009, 10, 321–322, doi:10.1016/s1470-2045(09)70096-8.
- Chen, Z.; Schiffman, M.; Herrero, R.; DeSalle, R.; Anastos, K.; Segondy, M.; Sahasrabuddhe, V.V.; Gravitt, P.E.; Hsing, A.W.; Burk, R.D. Evolution and Taxonomic Classification of Human Papillomavirus 16 (HPV16)-Related Variant Genomes: HPV31, HPV33, HPV35, HPV52, HPV58 and HPV67. PLOS ONE 2011, 6, e20183, . [CrossRef]
- Clifford, G.M.; Howell-Jones, R.; Franceschi, S. Judging the carcinogenicity of human papillomavirus types by single/multiple infection ratio in cervical cancer. Int. J. Cancer 2010, 129, 1792–1794, . [CrossRef]
- Chen, Z.; Schiffman, M.; Herrero, R.; DeSalle, R.; Anastos, K.; Segondy, M.; Sahasrabuddhe, V.V.; Gravitt, P.E.; Hsing, A.W.; Chan, P.K.; et al. Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61). Virology 2018, 516, 86–101, . [CrossRef]
- Fitch, W.M. Rate of change of concomitantly variable codons. J. Mol. Evol. 1971, 1, 84–96, . [CrossRef]
- Suzuki, Y. New Methods for Detecting Positive Selection at Single Amino Acid Sites. J. Mol. Evol. 2004, 59, 11–19, . [CrossRef]
- Murrell, B.; Wertheim, J.O.; Moola, S.; Weighill, T.; Scheffler, K.; Pond, S.L.K. Detecting Individual Sites Subject to Episodic Diversifying Selection. PLOS Genet. 2012, 8, e1002764, . [CrossRef]
- King, K.M.; Rajadhyaksha, E.V.; Tobey, I.G.; Van Doorslaer, K. Synonymous nucleotide changes drive papillomavirus evolution. Tumour Virus Res. 2022, 14, 200248, . [CrossRef]
- Zhu, B.; Xiao, Y.; Yeager, M.; Clifford, G.; Wentzensen, N.; Cullen, M.; Boland, J.F.; Bass, S.; Steinberg, M.K.; Raine-Bennett, T.; et al. Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance. Nat. Commun. 2020, 11, 886, . [CrossRef]
- Mirabello, L.; Yeager, M.; Yu, K.; Clifford, G.M.; Xiao, Y.; Zhu, B.; Cullen, M.; Boland, J.F.; Wentzensen, N.; Nelson, C.W.; et al. HPV16 E7 Genetic Conservation Is Critical to Carcinogenesis. Cell 2017, 170, 1164–1174.e6, . [CrossRef]
- Shackelton, L.A.; Parrish, C.R.; Holmes, E.C. Evolutionary Basis of Codon Usage and Nucleotide Composition Bias in Vertebrate DNA Viruses. J. Mol. Evol. 2006, 62, 551–563, . [CrossRef]
- Pinheiro, M.; Harari, A.; Schiffman, M.; Clifford, G.M.; Chen, Z.; Yeager, M.; Cullen, M.; Boland, J.F.; Raine-Bennett, T.; Steinberg, M.; et al. Phylogenomic Analysis of Human Papillomavirus Type 31 and Cervical Carcinogenesis: A Study of 2093 Viral Genomes. Viruses 2021, 13, 1948, . [CrossRef]
- Mirabello, L.; Yeager, M.; Cullen, M.; Boland, J.F.; Chen, Z.; Wentzensen, N.; Zhang, X.; Yu, K.; Yang, Q.; Mitchell, J.; et al. HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women. JNCI J. Natl. Cancer Inst. 2016, 108, . [CrossRef]
- Pinheiro, M.; Gage, J.C.; Clifford, G.M.; Demarco, M.; Cheung, L.C.; Chen, Z.; Yeager, M.; Cullen, M.; Boland, J.F.; Chen, X.; et al. Association of HPV35 with cervical carcinogenesis among women of African ancestry: Evidence of viral-host interaction with implications for disease intervention. Int. J. Cancer 2020, 147, 2677–2686, . [CrossRef]
- Bee, K.J.; Gradissimo, A.; Chen, Z.; Harari, A.; Schiffman, M.; Raine-Bennett, T.; Castle, P.E.; Clarke, M.; Wentzensen, N.; Burk, R.D. Genetic and Epigenetic Variations of HPV52 in Cervical Precancer. Int. J. Mol. Sci. 2021, 22, 6463, . [CrossRef]
- Kovacic, M.B.; Castle, P.E.; Herrero, R.; Schiffman, M.; Sherman, M.E.; Wacholder, S.; Rodriguez, A.C.; Hutchinson, M.L.; Bratti, M.C.; Hildesheim, A.; et al. Relationships of Human Papillomavirus Type, Qualitative Viral Load, and Age with Cytologic Abnormality. Cancer Res 2006, 66, 10112–10119, . [CrossRef]
- Berumen, J.; Ordoñez, R.M.; Lazcano, E.; Salmeron, J.; Galvan, S.C.; Estrada, R.A.; Yunes, E.; Garcia-Carranca, A.; Gonzalez-Lira, G.; la Campa, A.M.-D. Asian-American Variants of Human Papillomavirus 16 and Risk for Cervical Cancer: a Case-Control Study. JNCI J. Natl. Cancer Inst. 2001, 93, 1325–1330, . [CrossRef]
- Hildesheim, A.; Herrero, R.; E Castle, P.; Wacholder, S.; Bratti, M.C.; E Sherman, M.; Lorincz, A.T.; Burk, R.D.; Morales, J.; Rodriguez, A.C.; et al. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica. Br. J. Cancer 2001, 84, 1219–1226, . [CrossRef]
- Xi, L.F.; Koutsky, L.A.; Hildesheim, A.; Galloway, D.A.; Wheeler, C.M.; Winer, R.L.; Ho, J.; Kiviat, N.B. Risk for High-Grade Cervical Intraepithelial Neoplasia Associated with Variants of Human Papillomavirus Types 16 and 18. Cancer Epidemiology Biomarkers Prev. 2007, 16, 4–10, . [CrossRef]
- Chen, Z., et al., K-Mer Analyses Reveal Different Evolutionary Histories of Alpha, Beta, and Gamma Papillomaviruses. Int J Mol Sci, 2021. 22(17).
- Badal, S.; Badal, V.; E Calleja-Macias, I.; Kalantari, M.; Chuang, L.S.; Li, B.F.; Bernard, H.-U. The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology 2004, 324, 483–492, . [CrossRef]
- Mirabello, L.; Sun, C.; Ghosh, A.; Rodriguez, A.C.; Schiffman, M.; Wentzensen, N.; Hildesheim, A.; Herrero, R.; Wacholder, S.; Lorincz, A.; et al. Methylation of Human Papillomavirus Type 16 Genome and Risk of Cervical Precancer in a Costa Rican Population. JNCI J. Natl. Cancer Inst. 2012, 104, 556–565, . [CrossRef]
- Ekanayake Weeramange, C.E.; Tang, K.D.; Vasani, S.; Langton-Lockton, J.; Kenny, L.; Punyadeera, C. DNA Methylation Changes in Human Papillomavirus-Driven Head and Neck Cancers. Cells 2020, 9, doi:10.3390/cells9061359.
- Wentzensen, N.; Sun, C.; Ghosh, A.; Kinney, W.; Mirabello, L.; Wacholder, S.; Shaber, R.; LaMere, B.; Clarke, M.; Lorincz, A.T.; et al. Methylation of HPV18, HPV31, and HPV45 Genomes and Cervical Intraepithelial Neoplasia Grade 3. JNCI J. Natl. Cancer Inst. 2012, 104, 1738–1749, . [CrossRef]
- Upadhyay, M.; Samal, J.; Kandpal, M.; Vasaikar, S.; Biswas, B.; Gomes, J.; Vivekanandan, P. CpG Dinucleotide Frequencies Reveal the Role of Host Methylation Capabilities in Parvovirus Evolution. J. Virol. 2013, 87, 13816–13824, . [CrossRef]
- Xi, L.F.; Jiang, M.; Shen, Z.; Hulbert, A.; Zhou, X.-H.; Lin, Y.-Y.; Kiviat, N.B.; Koutsky, L.A. Inverse Association between Methylation of Human Papillomavirus Type 16 DNA and Risk of Cervical Intraepithelial Neoplasia Grades 2 or 3. PLOS ONE 2011, 6, e23897, . [CrossRef]
- Piyathilake, C.J.; Macaluso, M.; Alvarez, R.D.; Chen, M.; Badiga, S.; Edberg, J.C.; Partridge, E.E.; Johanning, G.L. A higher degree of methylation of the HPV 16 E6 gene is associated with a lower likelihood of being diagnosed with cervical intraepithelial neoplasia. Cancer 2010, 117, 957–963, . [CrossRef]
- Clarke, M.A.; Wentzensen, N.; Mirabello, L.; Ghosh, A.; Wacholder, S.; Harari, A.; Lorincz, A.; Schiffman, M.; Burk, R.D. Human Papillomavirus DNA Methylation as a Potential Biomarker for Cervical Cancer. Cancer Epidemiology Biomarkers Prev. 2012, 21, 2125–2137, . [CrossRef]
- Feng, C.; Dong, J.; Chang, W.; Cui, M.; Xu, T. The Progress of Methylation Regulation in Gene Expression of Cervical Cancer. Int. J. Genom. 2018, 2018, 8260652, . [CrossRef]
- Vartanian, J.-P.; Guétard, D.; Henry, M.; Wain-Hobson, S. Evidence for Editing of Human Papillomavirus DNA by APOBEC3 in Benign and Precancerous Lesions. Science 2008, 320, 230–233, . [CrossRef]
- Warren, C.J.; Westrich, J.A.; Van Doorslaer, K.; Pyeon, D. Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression. Viruses 2017, 9, 233, . [CrossRef]
- Poulain, F.; Lejeune, N.; Willemart, K.; Gillet, N.A. Footprint of the host restriction factors APOBEC3 on the genome of human viruses. PLOS Pathog. 2020, 16, e1008718, . [CrossRef]
- Xu, W.K.; Byun, H.; Dudley, J.P. The Role of APOBECs in Viral Replication. Microorganisms 2020, 8, 1899, . [CrossRef]
- A Burgers, W.; Blanchon, L.; Pradhan, S.; de Launoit, Y.; Kouzarides, T.; Fuks, F. Viral oncoproteins target the DNA methyltransferases. Oncogene 2007, 26, 1650–1655, . [CrossRef]
- Au Yeung, C.L.; Tsang, W.P.; Tsang, T.Y.; Co, N.N.; Yau, P.L.; Kwok, T.T. HPV-16 E6 upregulation of DNMT1 through repression of tumor suppressor p53.. Oncol. Rep. 2010, 24, 1599–1604, . [CrossRef]
- Sen, P.; Ganguly, P.; Ganguly, N. Modulation of DNA methylation by human papillomavirus E6 and E7 oncoproteins in cervical cancer (Review). Oncol. Lett. 2018, 15, 11–22, . [CrossRef]
- Wallace, N.A.; Münger, K. The curious case of APOBEC3 activation by cancer-associated human papillomaviruses. PLOS Pathog. 2018, 14, e1006717, . [CrossRef]
- Zhe, X.; Xin, H.; Pan, Z.; Jin, F.; Zheng, W.; Li, H.; Li, D.; Cao, D.; Li, Y.; Zhang, C.; et al. Genetic variations in E6, E7 and the long control region of human papillomavirus type 16 among patients with cervical lesions in Xinjiang, China. Cancer Cell Int. 2019, 19, 65, . [CrossRef]
- Woo, P.C.; Wong, B.H.; Huang, Y.; Lau, S.K.; Yuen, K.-Y. Cytosine deamination and selection of CpG suppressed clones are the two major independent biological forces that shape codon usage bias in coronaviruses. Virology 2007, 369, 431–442, . [CrossRef]
- Van Doorslaer, K. Evolution of the Papillomaviridae. Virology 2013, 445, 11–20, . [CrossRef]
- Liu, P.; Qiu, Y.; Xing, C.; Zhou, J.-H.; Yang, W.-H.; Wang, Q.; Li, J.-Y.; Han, X.; Zhang, Y.-Z.; Ge, X.-Y. Detection and genome characterization of two novel papillomaviruses and a novel polyomavirus in tree shrew (Tupaia belangeri chinensis) in China. Virol. J. 2019, 16, 35, . [CrossRef]
- Latsuzbaia, A.; Wienecke-Baldacchino, A.; Tapp, J.; Arbyn, M.; Karabegović, I.; Chen, Z.; Fischer, M.; Mühlschlegel, F.; Weyers, S.; Pesch, P.; et al. Characterization and Diversity of 243 Complete Human Papillomavirus Genomes in Cervical Swabs Using Next Generation Sequencing. Viruses 2020, 12, 1437, . [CrossRef]
- Lou, H.; Boland, J.F.; Torres-Gonzalez, E.; Albanez, A.; Zhou, W.; Steinberg, M.K.; Diaw, L.; Mitchell, J.; Roberson, D.; Cullen, M.; et al. The D2 and D3 Sublineages of Human Papilloma Virus 16–Positive Cervical Cancer in Guatemala Differ in Integration Rate and Age of Diagnosis. Cancer Res 2020, 80, 3803–3809, . [CrossRef]
- Liu, W.; Li, J.; Du, H.; Ou, Z. Mutation Profiles, Glycosylation Site Distribution and Codon Usage Bias of Human Papillomavirus Type 16. Viruses 2021, 13, 1281, . [CrossRef]
- Tlučková, K.; Marušič, M.; Tóthová, P.; Bauer, L.; Šket, P.; Plavec, J.; Viglasky, V. Human Papillomavirus G-Quadruplexes. Biochemistry 2013, 52, 7207–7216, . [CrossRef]
- Cadet, J.; Douki, T.; Ravanat, J.-L. One-electron oxidation of DNA and inflammation processes. Nat. Chem. Biol. 2006, 2, 348–349, . [CrossRef]
- Krieg, A.M.; Wu, T.; Weeratna, R.; Efler, S.M.; Love-Homan, L.; Yang, L.; Yi, A.-K.; Short, D.; Davis, H.L. Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs. Proc. Natl. Acad. Sci. 1998, 95, 12631–12636, . [CrossRef]
- Miller, L.S. Toll-Like Receptors in Skin. Adv. Dermatol. 2008, 24, 71–87, . [CrossRef]
- Hasan, U.A.; Zannetti, C.; Parroche, P.; Goutagny, N.; Malfroy, M.; Roblot, G.; Carreira, C.; Hussain, I.; Müller, M.; Taylor-Papadimitriou, J.; et al. The Human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter. J. Exp. Med. 2013, 210, 1369–1387, . [CrossRef]
- Pohar, J.; Yamamoto, C.; Fukui, R.; Cajnko, M.-M.; Miyake, K.; Jerala, R.; Benčina, M. Selectivity of Human TLR9 for Double CpG Motifs and Implications for the Recognition of Genomic DNA. J. Immunol. 2017, 198, 2093–2104, . [CrossRef]
- Cannella, F.; Pierangeli, A.; Scagnolari, C.; Cacciotti, G.; Tranquilli, G.; Stentella, P.; Recine, N.; Antonelli, G. TLR9 is expressed in human papillomavirus-positive cervical cells and is overexpressed in persistent infections. Immunobiology 2015, 220, 363–368, . [CrossRef]
- King, K.; Larsen, B.B.; Gryseels, S.; Richet, C.; Kraberger, S.; Jackson, R.; Worobey, M.; Harrison, J.S.; Varsani, A.; Van Doorslaer, K. Coevolutionary Analysis Implicates Toll-Like Receptor 9 in Papillomavirus Restriction. mBio 2022, 13, e0005422, . [CrossRef]
- Rogers, A.; Waltke, M.; Angeletti, P.C. Evolutionary variation of papillomavirus E2 protein and E2 binding sites. Virol. J. 2011, 8, 379–379, . [CrossRef]
- Newhouse, C.D.; Silverstein, S.J. Orientation of a Novel DNA Binding Site Affects Human Papillomavirus-Mediated Transcription and Replication. J. Virol. 2001, 75, 1722–1735, . [CrossRef]
- Gao, R.; Kim, C.; Sei, E.; Foukakis, T.; Crosetto, N.; Chan, L.-K.; Srinivasan, M.; Zhang, H.; Meric-Bernstam, F.; Navin, N. Nanogrid single-nucleus RNA sequencing reveals phenotypic diversity in breast cancer. Nat. Commun. 2017, 8, 228, . [CrossRef]
- Ganapathiraju, M.K.; Subramanian, S.; Chaparala, S.; Karunakaran, K.B. A reference catalog of DNA palindromes in the human genome and their variations in 1000 Genomes. Hum. Genome Var. 2020, 7, 40, . [CrossRef]







Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).